Mixed cardiogenic and septic shock after NSTEMI: choosing an inotrope and judging fluid responsiveness
71-year-old woman, day 4 after an NSTEMI with LVEF 28%. She is now febrile to 38.9 °C, with MAP 62 mmHg on norepinephrine 0.30 µg/kg/min, heart rate 112 in sinus rhythm, CVP 17 mmHg, cardiac index 2.0 L/min/m², SVR 780 dyn·s·cm⁻⁵, ScvO₂ 58%, lactate 5.2 mmol/L and urine output 15 mL/h. POCUS shows severely reduced LV systolic function, an IVC of 2.4 cm with minimal respiratory variation, bilateral B-lines and a new right lower lobe consolidation with purulent sputum. She has bibasilar crackles and is 6 L positive since admission. One litre of crystalloid given two hours ago raised MAP from 58 to 62 mmHg but lowered ScvO₂ from 62% to 58%.
1. What shock states are present, and what is the next hemodynamic intervention? Explain why more fluid is the wrong reflex here.
Read the worked answer
Mixed shock
- Cardiac index 2.0 L/min/m² with SVR 780 dyn·s·cm⁻⁵ and a severely reduced ejection fraction = a cardiogenic component.
- Fever, lactate 5.2, low SVR and a new lobar pneumonia = a distributive/septic component.
- ScvO₂ 58% with a low cardiac index points to limited forward flow, not a primary oxygen-content problem.
Why not more fluid
CVP 17 mmHg, a dilated IVC with minimal variation, B-lines and crackles all predict fluid unresponsiveness. The 1 L bolus produced only a 4 mmHg MAP rise and a fall in ScvO₂ - consistent with dilutional anaemia, increased LV wall stress and worsening pulmonary oedema. More fluid treats a pressure problem she does not have.
Next intervention
- Start dobutamine 2.5 µg/kg/min, titrating toward 5 µg/kg/min, targeting cardiac index ≥2.2 L/min/m², lactate clearance and urine output; maintain norepinephrine to keep MAP ≥65 mmHg, because coronary perfusion after recent myocardial injury matters.
- Treat the sepsis: cultures, antibiotics within one hour, source assessment for the consolidation.
- Milrinone is an alternative only if renal function is preserved; it is vasodilatory, arrhythmogenic, and accumulates in kidney injury.
Bottom line: inotrope plus vasopressor plus sepsis treatment and reassessment in 1–2 hours, not another bolus.
2. The fellow proposes a passive leg raise to decide on a 500 mL bolus. What do you predict, how would you interpret it, and what would you actually give?
Read the worked answer
Pre-test probability is low
A dilated, minimally varying IVC, B-lines and known severe LV dysfunction all predict fluid unresponsiveness. The passive leg raise is still worth doing because it is non-invasive and reversible, but a positive result must be weighed against the harm of another 500 mL in a patient with pulmonary oedema whose ScvO₂ fell after the last bolus.
How to do it properly
Semi-recumbent at 45°, then trunk flat with legs raised to 45°; measure stroke volume (LVOT VTI on echo) or pulse pressure within 60–90 seconds of the change and again on return. It is unreliable with raised intra-abdominal pressure, and the leg raise must be passive.
Decision rule
- Negative (<10% rise in stroke volume or pulse pressure): no fluid.
- Positive: give 250 mL over 10 minutes, not 500 mL, and reassess the same variable. Stop for any fall in oxygenation or rise in work of breathing.
- In either case, do not use CVP to make the decision.
Bottom line: perform the leg raise, but predefine that even a positive test justifies only a 250 mL aliquot with immediate reassessment - in this context fluid is the higher-risk option.
3. Two hours into dobutamine at 5 µg/kg/min her MAP falls to 54 mmHg with cardiac index 2.6 L/min/m², SVR 620 dyn·s·cm⁻⁵, and runs of non-sustained VT. What now?
Read the worked answer
What is happening
A rising cardiac index with falling SVR is dobutamine-induced vasodilation, and the non-sustained VT is its arrhythmogenic effect. Both are dangerous four days after an NSTEMI, when MAP and coronary perfusion pressure need to be defended.
Options, in order of preference
- Keep norepinephrine and add vasopressin 0.03 U/min - catecholamine-sparing, less arrhythmogenic, and effective via V1 receptors even in acidosis.
- Or switch dobutamine to epinephrine 0.05–0.10 µg/kg/min, which provides inotropy and vasoconstriction in one agent at the cost of more tachycardia and arrhythmia.
- Reduce dobutamine to the lowest rate that maintains cardiac index ≥2.2 L/min/m²; do not accept MAP <65 mmHg with recent myocardial injury.
Also do now
- Correct potassium, magnesium and oxygenation; check ECG and troponin before blaming the drug for ongoing ischaemia.
- Repeat echocardiography to look for a new mechanical complication or further decline in LV function.
- If perfusion remains inadequate on two agents, discuss mechanical circulatory support with cardiology - the window for an Impella or intra-aortic balloon pump is while she is still salvageable, not after multi-organ failure.
Bottom line: defend MAP with vasopressin, minimise dobutamine's vasodilator and arrhythmic effects, and actively look for ischaemia before escalating.